Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Scientific Reports|September 30, 2021
Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patientsAntonio Alcaraz, Alfredo Rodríguez-Antolín, Joaquín Carballido-Rodríguez, et al.
Reumatologia Clinica|April 21, 2025
Situational analysis of interventional rheumatology in Spain: Multicenter observational studyMarco Aurelio Ramírez Huaranga, Juan Carlos Quevedo Abeledo, Julio Sánchez Martin, et al.
Journal of Clinical Medicine|September 12, 2020
Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST StudyAntonio Alcaraz, Alfredo Rodríguez-Antolín, Joaquín Carballido-Rodríguez, et al.
Journal of Clinical Medicine|February 25, 2022
Efficacy and Safety of the Hexanic Extract of <i>Serenoa repens</i> vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical StudyAntonio Alcaraz, Mauro Gacci, Vincenzo Ficarra, et al.
Journal of Clinical Medicine|July 9, 2022
Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of <i>Serenoa repens</i> versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical StudyAntonio Alcaraz, David Castro-Díaz, Mauro Gacci, et al.
Seminars in Arthritis and Rheumatism|March 21, 2025
Real-world evidence of the antifibrotic nintedanib in rheumatoid arthritis-interstitial lung disease. National multicenter study of 74 patientsBelén Atienza-Mateo, Ana Serrano-Combarro, Jesús Loarce Martos, et al.
European Urology|April 18, 2017
Consensus Statement of the European Urology Association and the European Urogynaecological Association on the Use of Implanted Materials for Treating Pelvic Organ Prolapse and Stress Urinary IncontinenceChristopher R Chapple, Francisco Cruz, Xavier Deffieux, et al.
Neurourology and Urodynamics|November 23, 2013
The 3-day bladder diary is a feasible, reliable and valid tool to evaluate the lower urinary tract symptoms in womenMiguel A Jimenez-Cidre, Luis Lopez-Fando, Manuel Esteban-Fuertes, et al.
Scientific Reports|June 17, 2020
Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritisFernanda Genre, Javier Rueda-Gotor, Sara Remuzgo-Martínez, et al.
Therapeutic Advances in Musculoskeletal Disease|August 11, 2021
Potential relation of cardiovascular risk factors to disease activity in patients with axial spondyloarthritisIván Ferraz-Amaro, Javier Rueda-Gotor, Fernanda Genre, et al.
Pageof 15